Catalyst Wire Dossier Catalyst Wire Dossier

RESILIA Tissue Aortic Bioprosthesis

· Edwards Lifesciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RESILIA Tissue Aortic Bioprosthesis, covering 2024-05-09 to 2024-05-09. Get the full timeline:

Most recent: Clinical Trial Update: RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65

See pricing